+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
From
From
From
Gout - Pipeline Insight, 2024 - Product Thumbnail Image

Gout - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
From
Chronic Rhinosinusitis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Rhinosinusitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Seborrhoeic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Endometriosis - Pipeline Insight, 2024 - Product Thumbnail Image

Endometriosis - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • March 2025
  • 180 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
From
Scleroderma - Pipeline Insight, 2024 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
Autoimmune Hepatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Psoriasis vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Gouty Arthritis (Gout) - Pipeline Insight, 2024 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Still's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Still's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more